While Li et al. (2017) demonstrated that high tumor stage, positive lymph nodes, and high MALAT1 expression were independent prognostic indicators for OS of bladder cancer patients, and suggested that high MALAT1 expression could be considered as a potential therapeutic target of bladder cancer. This evidence concerns the gene MALAT1 and neoplasm.